May 2016

The Department of Health and Human Services' Office of Civil Rights is stepping up its enforcement efforts. Phase 2 of its HIPAA…

The United States House Committee on Energy and Commerce, Subcommittee on Health held a hearing on Tuesday, May 17,…

Vermont is soon to be the first state in the nation that requires pharmaceutical manufacturers to explain the reasons…

Europe adopted a new Code of Ethical Business Practice late last year. This article explores the purpose of the new Code,…

Aegerion Pharmaceuticals has reached agreements in principle with the Department of Justice ("DOJ") and the Securities and…

Consolidation is happening in insurers and health systems throughout the country. A recent legal case in Louisiana sheds…

The American College of Cardiology recently held the 65th Annual Scientific Session and Expo, where several sessions focused on…

The Pharmaceutical Summit on Business and Compliance Issues in Managed Markets is set to take place June 8 through June 9, 2016,…

The Senate Finance Committee Majority Staff recently issued a report entitled, “Physician Owned Distributorships: An Update on Key…

We have been talking about the opioid addiction in America for several months now, from Congressional hearings, to new…